They made the first anti-VEGF drug 20+ years ago. Now two longtime partners have $65M to spot new eye drugs
Almost 30 years ago, when David Guyer and Anthony Adamis were still medical school professors — at New York University and Harvard, respectively — the duo began …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
